AlphaGrep UK Ltd’s West Pharmaceutical WST Stock Holding History

AlphaGrep UK Ltd’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,244	Closed	-$617K	–	942
2025 Q4	$617K	Buy	+2,244	New	+$614K	0.21%	137

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK Ltd's WST Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 2,244 shares — an estimated $617K sold.

AlphaGrep UK Ltd first reported a position in WST in Q4 2025 and held it in 1 quarter. The position peaked at $617K in Q4 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

AlphaGrep UK Ltd reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 2,244 West Pharmaceutical shares in Q1 2026, an estimated $617K.
AlphaGrep UK Ltd first reported a position in West Pharmaceutical in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's West Pharmaceutical position peaked at $617K in Q4 2025.
754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.